YZi Labs Makes First Biotech Investment in Renewal Bio to Address Global Organ Shortages!

@YZiLabs has announced its first-ever biotech investment, backing Renewal Bioz a regenerative medicine company pioneering lab-grown, DNA-identical human cells and tissues to combat global organ shortages.

Renewal Bio’s proprietary Stembroid™ platform reprograms patient-derived cells into functional human tissues, enabling breakthroughs in treatments for leukemia, immune disorders, and organ failure.

The funding will accelerate pre-clinical development of Stembroid-derived hematopoietic stem cells (HSCs) and expand R&D into liver, heart, and pancreatic regeneration.